Trial Details

Recruiting
Basic Information
Clinical ID c2226
Identifier NCT05687474
Trial Title Universal Genomic Newborn Screening in the Wallonia-Brussels Federation: Baby Detect
Trial URL Visit Original Page
Study Information
Study Results

No results available

Conditions Congenital Adrenal Hyperplasia;Familial Hyperinsulinemic Hypoglycemia 1;Phosphoglucomutase 1 Deficiency;Maturity Onset Diabetes of the Young;Cystic Fibrosis;Hypophosphatasia, Infantile;Congenital Hypothyroidism;Deficit in Anterior Pituitary Function and Variable Immunodeficiency;Pituitary Hormone Deficiency, Combined;Diamond Blackfan Anemia;Wiskott-Aldrich Syndrome;Fanconi Anemia;Hemophilia a;Hemophilia B;Glucose 6 Phosphate Dehydrogenase Deficiency;Alpha-Thalassemia;Sickle Cell Disease;Shwachman-Diamond Syndrome;Alpha 1-Antitrypsin Deficiency;Inflammatory Bowel Disease 25, Autosomal Recessive;Wilson Disease;Progressive Familial Intrahepatic Cholestasis;Crigler-Najjar Syndrome;Familial Chylomicronemia;Lysosomal Acid Lipase Deficiency;Familial Hemophagocytic Lymphocytosis;Griscelli Syndrome;Chediak-Higashi Syndrome;Severe Congenital Neutropenia;Severe Combined Immune Deficiency;Chronic Granulomatous Disease;Menkes Disease;Adrenoleukodystrophy;Smith-Lemli-Opitz Syndrome;Ataxia with Vitamin E Deficiency;Thiamine Metabolism Dysfunction Syndrome 5 (Episodic Encephalopathy Type);Thiamine Metabolism Dysfunction Syndrome 4 (Bilateral Striatal Degeneration and Progressive Polyneuropathy Type);Thiamine-Responsive Megaloblastic Anemia;Thiamine Metabolism Dysfunction Syndrome 2;Deficiency of GOT2;Cerebral Folate Transport Deficiency;Segawa Syndrome, Autosomal Recessive;Congenital Myasthenic Syndrome;Metachromatic Leukodystrophy;Sepiapterin Reductase Deficiency;Dopamine Beta Hydroxylase Deficiency;Glut1 Deficiency Syndrome;Late-Infantile Neuronal Ceroid Lipofuscinosis;Aromatic L-amino Acid Decarboxylase Deficiency;Charcot-Marie-Tooth Disease, Type 6C;Hereditary Hyperekplexia;Brain Dopamine-Serotonin Vesicular Transport Disease;Very Long Chain Hydroxy Acyl Dehydrogenase Deficiency;Tyrosinemia, Type I;Disaccharide Intolerance I;Beta Ketothiolase Deficiency;Phosphoglycerate Dehydrogenase Deficiency;Succinyl-Coa:3-Ketoacid Coa-Transferase Deficiency;Pyridoxine-5'-Phosphate Oxidase Deficiency;Pyridoxine-Dependent Epilepsy;Propionic Acidemia;Pompe Disease;Phenylalanine Hydroxylase Deficiency;Ornithine Transcarbamylase Deficiency;N Acetyl Glutamate Synthetase Deficiency;Riboflavin Deficiency;Maple Syrup Urine Disease;Medium Chain Acyl CoA Dehydrogenase Deficiency;Malonic Acidemia;Long-chain 3-hydroxyacyl-CoA Dehydrogenase Deficiency;Isovaleric Acidemia;Phosphoserine Aminotransferase Deficiency;Phosphoserine Phosphatase Deficiency;Hyperornithinemia-Hyperammonemia-Homocitrullinuria;S-Adenosylhomocysteine Hydrolase Deficiency;Mucopolysaccharidosis VII;Mucopolysaccharidosis VI;Mucopolysaccharidosis IV a;Mucopolysaccharidosis II;Mucopolysaccharidosis I;Transcobalamin Deficiency;Isolated Methylmalonic Acidemia;Cobalamin Deficiency;Homocystinuria;Holocarboxylase Synthetase Deficiency;Fanconi Bickel Syndrome;Glycogen Storage Disease;Glycine Encephalopathy;Glutaric Acidemia I;Glucose Galactose Malabsorption;Gaucher Disease, Type 1;Galactosemias;Fructosemia;Fructose-1,6-Diphosphatase Deficiency;Carbamoyl Phosphate Synthase 1 Deficiency;Citrullinemia Type II;Citrullinemia 1;Creatine Deficiency Syndrome;Systemic Primary Carnitine Deficiency;Carnitine Palmitoyltransferase Deficiency 2;Carnitine Palmitoyltransferase Deficiency 1;Carnitine Acylcarnitine Translocase Deficiency;Riboflavin Transporter Deficiency;Branched-Chain Keto Acid Dehydrogenase Kinase Deficiency;Andersen Tawil Syndrome;Timothy Syndrome;Jervell-Lange Nielsen Syndrome;Catecholaminergic Polymorphic Ventricular Tachycardia;Familial Hypertrophic Cardiomyopathy Type 4;Pseudohypoaldosteronism, Type II;Pseudohypoaldosteronism Type 1;Primary Hyperoxaluria;X Linked Hypophosphatemia;Hereditary Nephrogenic Diabetes Insipidus;Cystinosis;Congenital Nephrotic Syndrome, Finnish Type;Alport Syndrome;Hereditary Retinoblastoma;Biotinidase Deficiency;Aciduria, Argininosuccinic;Argininemia;Acyl-CoA Dehydrogenase Family, Member 9, Deficiency of;3-Hydroxy 3-Methyl Glutaric Aciduria;3-Hydroxy-3-Methylglutaryl-CoA Synthase 2 Deficiency
Interventions -
Participant Information
Sponsor Centre Hospitalier Universitaire de Liege
City -
Country/Region Belgium
Enrollment Criteria
Sex Requirement ALL
Age Requirement -
Study Design
Study Type Observational
Phase Not Available
Time Information
Start Date 2025-04-24
Primary Completion Date -
Completion Date -